WallStSmart
NYXH

Nyxoah

NASDAQ: NYXH · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$2.95
+0.68% today

Updated 2026-04-30

Market cap
$130.99M
P/E ratio
P/S ratio
13.07x
EPS (TTM)
$-2.77
Dividend yield
52W range
$3 – $9
Volume
0.1M

Nyxoah (NYXH) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-4.4%
Last 4 quarters
Revenue YoY growth
+346.7%
Most recent quarter
EPS YoY growth
-16.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-7.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-15.1%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.59+5.8%$3.06$3.08+0.7%
2025-11-13$-0.73-7.1%$5.89$5.00-15.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.62$-0.59+5.8%$5.64M+346.7%
2025-09-30$-0.68$-0.73-7.1%$1.97M+55.8%
2025-06-30$-0.65$-0.64+0.4%$1.34M+73.8%
2025-03-31$-0.51$-0.60-16.6%$1.06M-12.9%
2024-12-31$-0.50$-0.50-0.3%$1.26M-30.8%
2024-09-30$-0.46$-0.53-15.2%$1.27M+29.7%
2024-06-30$-0.39$-0.43-10.3%$771000.00-30.4%
2024-03-31$-0.40$-0.41-2.5%$1.22M+176.9%
2023-12-31$-0.37$-0.38-2.7%$1.82M
2023-09-30$-0.42$-0.27+35.7%$976000.00
2023-06-30$-0.41$-0.45-9.8%$1.11M
2023-03-31$-0.34$-0.46-35.3%$441000.00

Frequently asked questions

Has Nyxoah beaten earnings estimates?
Nyxoah has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -4.4% over the last 4 quarters.
How does NYXH stock react to earnings?
NYXH stock has moved an average of -7.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Nyxoah's revenue growth rate?
Nyxoah reported year-over-year revenue growth of +346.7% in its most recent quarter, with EPS growing -16.6% year-over-year.